Skip to content

H2020

eyePoC

Clinical validation of a new diagnostic and monitoring PoC medical device based on quantification of biomarkers in tear fluids to improve the quality of eye health care

Programme
Horizon 2020
Started
Ends
Duration
6 months
Total cost
EUR 71,429
EU contribution
EUR 50,000
Participants
2 from 2 countries
Topic
H2020_PHC-12-2014-1
Grant agreement
652132

Coordinated by Horus Pharma Sas (FRFrance).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
OrganisationCountryRoleEU contributionRecognised by
Horus Pharma SasFRFranceCoordinatorEUR 50,000PIC (1.00)
Bioftalmik S.L.ESSpainParticipantEUR 0PIC (1.00)

Changes of the consortium

First seen on with 2 participants from 2 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.